SCHEMBL1244429

SCHEMBL1244429

CN(C)CCN1CCN(CC(O)COCCC[Si](C)(C)CC[Si](C)(C)C)CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.40
KDM4E B2RXH2 4/20 0.40
USP2 O75604 2/20 0.40
ALOX15 P16050 1/20 0.40
SMN1; SMN2 Q16637 4/20 0.34
LMNA P02545 3/20 0.34
RAB9A P51151 2/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
HSP90AB1 P08238 1/20 0.33
KMT2A Q03164 4/20 0.33
MAPT P10636 2/20 0.33
GLA P06280 1/20 0.33
TSHR P16473 1/20 0.32
HSD17B10 Q99714 1/20 0.32
POLB P06746 1/20 0.32
MEN1 O00255 3/20 0.32
MAPK1 P28482 2/20 0.32
GAA P10253 1/20 0.32
HTT P42858 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1244968 0.87 ALDH1A1 (0.42) ALDH1A1KDM4EUSP2ALOX15SMN1; SMN2
SCHEMBL12621150 0.83 ALDH1A1 (0.45) ALDH1A1KDM4EUSP2ALOX15LMNA
SCHEMBL1245084 0.82 USP2 (0.46) ALDH1A1KDM4EUSP2ALOX15SMN1; SMN2
SCHEMBL1244331 0.81 SMN1; SMN2 (0.48) ALDH1A1KDM4EUSP2ALOX15SMN1; SMN2
SCHEMBL1242898 0.76 USP2 (0.37) USP2SMN1; SMN2LMNAHSD17B10HTT
SCHEMBL12926860 0.75 KDM4E (0.46) ALDH1A1KDM4EUSP2ALOX15SMN1; SMN2
SCHEMBL1001771 0.75 ALDH1A1 (0.40) ALDH1A1KDM4EUSP2ALOX15SMN1; SMN2
SCHEMBL13924016 0.73 USP2 (0.48) ALDH1A1KDM4EUSP2ALOX15SMN1; SMN2
SCHEMBL1245261 0.72 HTT (0.53) ALDH1A1USP2KMT2AMEN1HTT
SCHEMBL13705970 0.72 KDM4E (0.48) ALDH1A1KDM4EUSP2ALOX15SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2124545-B1 HYDROLYSIS RESISTANT ORGANOMODIFIED SILYLATED IONIC SURFACTANTS MOMENTIVE PERFORMANCE MAT INC (US) 2015-12-02 EP disclosed
EP-2124545-B1 HYDROLYSIS RESISTANT ORGANOMODIFIED SILYLATED IONIC SURFACTANTS MOMENTIVE PERFORMANCE MAT INC (US) 2015-12-02 EP disclosed
US-8569385-B2 Hydrolysis resistant organomodified silylated ionic surfactants MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2013-10-29 US disclosed
US-8569385-B2 Hydrolysis resistant organomodified silylated ionic surfactants MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2013-10-29 US disclosed
US-20110105428-A1 HYDROLYSIS RESISTANT ORGANOMODIFIED SILYLATED IONIC SURFACTANTS MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2011-05-05 US disclosed
US-7879916-B2 Anionic, cationic or zwitterionic disilane surfactants; stable over a wide pH range; for controlling wetting, spreading, foaming, and detergency on applied surfaces; aqueous solutions improve delivery of active ingredients MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2011-02-01 US disclosed
US-7879916-B2 Anionic, cationic or zwitterionic disilane surfactants; stable over a wide pH range; for controlling wetting, spreading, foaming, and detergency on applied surfaces; aqueous solutions improve delivery of active ingredients MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2011-02-01 US disclosed
EP-2124545-A1 HYDROLYSIS RESISTANT ORGANOMODIFIED SILYLATED IONIC SURFACTANTS Momentive Performance Materials Inc. (US) 2009-12-02 EP disclosed
US-20080167269-A1 HYDROLYSIS RESISTANT ORGANOMODIFIED SILYLATED IONIC SURFACTANTS MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2008-07-10 US disclosed
US-20080167269-A1 HYDROLYSIS RESISTANT ORGANOMODIFIED SILYLATED IONIC SURFACTANTS MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2008-07-10 US disclosed
US-20080167389-A1 Hydrolysis resistant organomodified silylated ionic surfactants MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2008-07-10 US disclosed
US-20080167389-A1 Hydrolysis resistant organomodified silylated ionic surfactants MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2008-07-10 US disclosed
WO-2008073397-A1 HYDROLYSIS RESISTANT ORGANOMODIFIED SILYLATED IONIC SURFACTANTS MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2008-06-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110105428-A1 HYDROLYSIS RESISTANT ORGANOMODIFIED SILYLATED IONIC SURFACTANTS MLNR, SSTR3, FOXM1 ALDH1A1 2282/4885KDM4E 1802/4885USP2 664/4885
US-20080167389-A1 Hydrolysis resistant organomodified silylated ionic surfactants MLNR, SSTR3, FOXM1 ALDH1A1 2282/4885KDM4E 1802/4885USP2 664/4885
US-20080167269-A1 HYDROLYSIS RESISTANT ORGANOMODIFIED SILYLATED IONIC SURFACTANTS MLNR, SSTR3, FOXM1 ALDH1A1 2282/4885KDM4E 1802/4885USP2 664/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.